pyrazines has been researched along with Infections, RNA Virus in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Daikoku, T; Shiraki, K | 1 |
Mori, M; Picarazzi, F; Saladini, F; Vicenti, I; Zazzi, M | 1 |
Abdelnabi, R; Delang, L; Neyts, J | 1 |
Barnard, DL; Furuta, Y; Gowen, BB; Julander, JG; Morrey, JD; Sakamoto, K; Shiraki, K; Smee, DF; Takahashi, K | 1 |
4 review(s) available for pyrazines and Infections, RNA Virus
Article | Year |
---|---|
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections.
Topics: Amides; Animals; Antiviral Agents; Humans; Influenza, Human; Pyrazines; RNA Virus Infections | 2020 |
Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge.
Topics: Amides; Antiviral Agents; Coronavirus; Drug Design; Enzyme Inhibitors; Flavivirus; Hepacivirus; Humans; Pyrazines; RNA Virus Infections; RNA Viruses; RNA-Dependent RNA Polymerase; Small Molecule Libraries | 2020 |
Favipiravir as a potential countermeasure against neglected and emerging RNA viruses.
Topics: Amides; Antiviral Agents; Clinical Trials as Topic; Humans; Pyrazines; RNA Virus Infections; RNA Viruses; Treatment Outcome | 2018 |
T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections.
Topics: Amides; Animals; Antiviral Agents; Nucleosides; Pyrazines; RNA Virus Infections; RNA Viruses; RNA-Dependent RNA Polymerase; Viral Proteins | 2009 |